United States Department of Veterans Affairs
United States Department of Veterans Affairs
National Hepatitis C Program
Providers' Home > Resources > Journal ArticlesEnlarge Text Size:Small Font SizeMedium Font SizeLarge Font Size

Resources

In the Literature

bulletNew!Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
Di Bisceglie AM, et al. N Engl J Med. 2008 Dec 4;359(23):2429-41.
bulletNew!Improving clinical quality and efficiency with simple practice adjustments.
Pocha C. Current Clinical Practice. 2008 Dec; 2(3):1-6.

Previous Articles by Topic

bulletEpidemiology & Natural Science
bulletPrevention & Transmission
bulletTesting & Counseling
bulletClinical Management
bulletTreatment
bulletHIV Coinfection
bulletHepatitis C and Associated Diseases
bulletOther Types of Hepatitis
bulletCirrhosis
bulletHepatocellular Carcinoma
bulletLiver Transplant

Epidemiology & Natural Science

bulletAntibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ikeda K, et al. Ann Intern Med. 2007 May 1;146(9):649-56.
bulletElevated prevalence of hepatitis C infection in users of United States veterans medical centers
Dominitz JA, et al. Hepatology. 2005;41:88-96.
bulletHepatitis C tested prevalence and comorbidities among veterans in the US Northwest
Sloan KL, et al. J Clin Gastroenterol. 2004 Mar;38(3):279-84.
bulletDiagnosis, management, and treatment of hepatitis C
Strader DB, et al. Hepatology. 2004 Apr;39(4):1147-71.
bulletCDC: Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites -- Connecticut, 1999
Morbidity and Mortality Weekly Report, July 13, 2001.
bulletCDC: Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics -- selected locations, United States, 1991-2000
Morbidity and Mortality Weekly Report, July 28, 2000.

Prevention & Transmission

bulletDetection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing
Stramer, S, et al. N Engl J Med. 2004 Aug 19;351(8):760-8.

Testing & Counseling

bulletMolecular diagnostics of hepatitis C virus infection: a systematic review.
Scott JD, Gretch DR. JAMA. 2007 Feb 21;297(7):724-32.
bullet Screening for hepatitis C virus infection in adults: Recommendation statement
US Preventive Services Task Force, Ann Intern Med. 2004 Mar 16;140(6):462-4.
bulletScreening for hepatitis C virus infection: A review of the evidence for the US Preventive Services Task Force
Chou, R, et al. Ann Intern Med. 2004 Mar 16;140(6):465-79.
bulletSummaries for patients: Screening for hepatitis C virus infection: Recommendations from the US Preventive Service Task Force
Ann Intern Med. 2004 Mar 16;140(6):I62.

Clinical Management

bulletNew!Improving clinical quality and efficiency with simple practice adjustments.
Pocha C. Current Clinical Practice. 2008 Dec; 2(3):1-6.
bulletPrevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis (AASLD Practice Guidelines).
Garcia-Tsao G, et al. Hepatology. 2007 Sep;46(3):922-38.
bulletPrevalence of gallbladder disease among persons with hepatitis C virus infection in the United States
Bini EJ and McGready J. Hepatology. 2005 May;41(5):1029-36.
bulletDiagnosis, management, and treatment of hepatitis C
Strader DB, et al. Hepatology. 2004 Apr;39(4):1147-71.
bulletRisks of a range of alcohol intake on hepatitis C-related fibrosis
Monto A, et al. Hepatology. 2004 Mar;39(3):826-34.
bulletPrevalence and predictors of herbal medication use in veterans with chronic hepatitis C
Siddiqui U, et al. J Clin Gastroenterol. 2004 Aug;38(7):605-10.
bulletComplementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review
Coon JT and Ernst E. J Hepatol. 2004 Mar;40(3):491-500.

Treatment

bulletNew!Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
Di Bisceglie AM, et al. N Engl J Med. 2008 Dec 4;359(23):2429-41.
bulletRacial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study.
Rousseau CM, Ioannou GN, Todd-Stenberg JA, et al. Am J Public Health. 2008 May;98(5):846-52.
bulletTelaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
Kieffer TL, et al. Hepatology. 2007 Sep;46(3):631-9.
bulletAntiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
Forestier N, et al. Hepatology. 2007 Sep;46(3):640-8.
bulletImpact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Shiffman ML, et al. Gastroenterology. 2007 Jan;132(1):103-12.
bulletPeginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.
Mangia A, et al. N Engl J Med. 2005 Jun 23;352(25):2609-17.
bulletPeginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
Muir AJ, et al. N Engl J Med. 2004 May 27;350(22):2265-71.
bulletNeuropsychiatric side effects of HCV therapy and their treatment: focus on IFNa-induced depression.
Hauser, P. Gastroenterology Clin N Am. 2004; 33;S37-S50.
bulletA prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.
Dieperink E, Ho SB, Thuras P, Willenbring ML. Psychosomatics. 2003 Mar-Apr;44(2):104-12.

HIV Coinfection

bulletManagement of chronic hepatitis C virus infection in HIV-infected patients.
Pol S, Soriano V. Clin Infect Dis. 2008 Jul 1;47(1):94-101.
bulletHIV and Liver Disease Forum: Conference Proceedings [pdf]
Kenneth E. Sherman, KE, et al. Hepatology. 2007 Jun;45(6):1566-77.
bulletViral hepatitis in HIV infection.
Koziel MJ, Peters MG. N Engl J Med. 2007 Apr 5;356(14):1445-54.
bulletPeginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
Torriani FJ, et al. N Engl J Med. 2004 Jul 29;351(5):438-50.
bulletPeginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
Chung RT, et al. N Engl J Med. 2004 Jul 29;351(5):451-9.

Hepatitis C and Associated Diseases

bulletScreening for diabetes and prediabetes.
Kenealy T, Elley CR, Arroll B. Lancet. 2007 Dec 8;370(9603):1888-9.
bulletDo high lipids help clearance of hepatitis C?
Ryder S. Gut. 2007 Aug;56(8):1044-5.
bulletHepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication
Huang JF, Dai CY, Hwang SJ, et al. Am J Gastroenterol. 2007 Jun;102(6):1237-43.
bulletHigh prevalence of hepatitis C virus infection in diabetic patients.
Simó R, Hernández C, Genescà J, et al. Diabetes Care. 1996 Sep;19(9):998-1000.

Other Types of Hepatitis

bulletChronic hepatitis B. (AASLD Practice Guidelines)
Lok AS and McMahon BJ. Hepatology. 2007 Feb;45(2):507-39.
bulletPeginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
Marcellin P, et al. N Engl J Med. 2004 Sep 16;351(12):1206-17.

Cirrhosis

bulletThe management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Moore KP, Wong F, Gines P, et al. Hepatology. 2003;38:258-66.
bulletIs obesity a risk factor for cirrhosis related death or hospitalization? A population-based cohort study.
GN, Weiss NS, Kowdley KV, Dominitz JA. Gastroenterology. 2003 Oct;125(4):1053-9.

Hepatocellular Carcinoma

bulletSorafenib in advanced hepatocellular carcinoma. Llovet JM, Ricci S, Mazzaferro V, et al. N Engl J Med. 2008 Jul 24;359(4):378-90.
bulletAntibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ikeda K, et al. Ann Intern Med. 2007 May 1;146(9):649-56.
bulletManagement of Hepatocellular Carcinoma. (AASLD Practice Guideline)
Bruix J and Sherman M. Hepatology. 2005 Nov;42(5):1208-36.
bulletRole of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis
Nguyen MH, et al. Clin Gastroenterol Hepatol. 2004 Sep;2(9):820-4.
bulletClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference [pdf]
Bruix J, et al. Journal of Hepatology. 2001 35:421-430.

Liver Transplant

bulletSummary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era
Olthoff KM, et al. Liver Transpl. 2004 Oct;10(10 Suppl 2):A6-22.
bulletComparative analysis of outcome following liver transplantation in US veterans
Austin GL, et al. Am J Transplant 2004 May;4(5):788-95.
bulletReport of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C
Wiesner RH, et al. Liver Transpl. 2003 Nov;9(11):S1-9.
iconPrint this page
iconEmail this page

Hepatitis C is a part of the Office of Public Health and Environmental Hazards.

OPHEH | Environmental Agents | Emergency Management | Public Health
Occupational Health | Women's Health | Environmental Epidemiology